Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Raised to $203 at BofA Securities

April 29, 2026 2:58 PM
BofA Securities analyst Jason Zemansky raised the price target on Biogen (NASDAQ: BIIB) to $203.00 (from $200.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change